152 related articles for article (PubMed ID: 17239601)
1. Selective L-nitroargininylaminopyrrolidine and L-nitroargininylaminopiperidine neuronal nitric oxide synthase inhibitors.
Seo J; Martásek P; Roman LJ; Silverman RB
Bioorg Med Chem; 2007 Mar; 15(5):1928-38. PubMed ID: 17239601
[TBL] [Abstract][Full Text] [Related]
2. Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water.
Seo J; Igarashi J; Li H; Martasek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2007 May; 50(9):2089-99. PubMed ID: 17425297
[TBL] [Abstract][Full Text] [Related]
3. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
4. Conformationally restricted dipeptide amides as potent and selective neuronal nitric oxide synthase inhibitors.
Ji H; Gómez-Vidal JA; Martasek P; Roman LJ; Silverman RB
J Med Chem; 2006 Oct; 49(21):6254-63. PubMed ID: 17034131
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.
Huang H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2013 Apr; 56(7):3024-32. PubMed ID: 23451760
[TBL] [Abstract][Full Text] [Related]
6. Potent and selective conformationally restricted neuronal nitric oxide synthase inhibitors.
Gómez-Vidal JA; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2004 Jan; 47(3):703-10. PubMed ID: 14736250
[TBL] [Abstract][Full Text] [Related]
7. Reduced amide bond peptidomimetics. (4S)-N-(4-amino-5-[aminoakyl]aminopentyl)-N'-nitroguanidines, potent and highly selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Roman LJ; Martásek P; Silverman RB
J Med Chem; 2001 Aug; 44(16):2667-70. PubMed ID: 11472219
[TBL] [Abstract][Full Text] [Related]
8. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of peptidomimetics as selective inhibitors and active site probes of nitric oxide synthases.
Huang H; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2000 Jul; 43(15):2938-45. PubMed ID: 10956202
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
[TBL] [Abstract][Full Text] [Related]
11. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
[TBL] [Abstract][Full Text] [Related]
13. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
Silverman RB
Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
[TBL] [Abstract][Full Text] [Related]
14. Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries.
Lekontseva O; Chakrabarti S; Jiang Y; Cheung CC; Davidge ST
J Pharmacol Exp Ther; 2011 Nov; 339(2):367-75. PubMed ID: 21807885
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
16. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.
Igarashi J; Li H; Jamal J; Ji H; Fang J; Lawton GR; Silverman RB; Poulos TL
J Med Chem; 2009 Apr; 52(7):2060-6. PubMed ID: 19296678
[TBL] [Abstract][Full Text] [Related]
17. Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker.
Wang HY; Qin Y; Li H; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2016 May; 59(10):4913-25. PubMed ID: 27050842
[TBL] [Abstract][Full Text] [Related]
18. Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
Li H; Xue F; Kraus JM; Ji H; Labby KJ; Mataka J; Delker SL; Martásek P; Roman LJ; Poulos TL; Silverman RB
Bioorg Med Chem; 2013 Mar; 21(5):1333-43. PubMed ID: 23352768
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of nitric oxide synthase inhibitors on endothelium-dependent and nitrergic nerve-mediated vasodilatation in the bovine ciliary artery.
Overend J; Martin W
Br J Pharmacol; 2007 Feb; 150(4):488-93. PubMed ID: 17211453
[TBL] [Abstract][Full Text] [Related]
20. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]